Literature DB >> 11082166

Cushing, cortisol, and cardiovascular disease.

J A Whitworth1, G J Mangos, J J Kelly.   

Abstract

Cushing's syndrome of glucocorticoid excess is named after the eminent Boston neurosurgeon Harvey W. Cushing (1869-1939). The recognition that glucocorticoid excess produces hypertension led to examination of the role of cortisol in essential hypertension, but it is only over the last decade that evidence has emerged to support the concept. Despite the widespread assumption that cortisol raises blood pressure as a consequence of renal sodium retention, there are few data consistent with the notion. Although it has a plethora of actions on brain, heart and blood vessels, kidney, and body fluid compartments, precisely how cortisol elevates blood pressure is unclear. Candidate mechanisms currently being examined include inhibition of the vasodilator nitric oxide system and increases in vasoconstrictor erythropoietin concentration.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11082166     DOI: 10.1161/01.hyp.36.5.912

Source DB:  PubMed          Journal:  Hypertension        ISSN: 0194-911X            Impact factor:   10.190


  55 in total

Review 1.  Metabolic impact of body fat distribution.

Authors:  C Gasteyger; A Tremblay
Journal:  J Endocrinol Invest       Date:  2002-11       Impact factor: 4.256

Review 2.  Mechanisms of hypertension: the expanding role of aldosterone.

Authors:  E Marie Freel; John M C Connell
Journal:  J Am Soc Nephrol       Date:  2004-08       Impact factor: 10.121

Review 3.  Hormones and antioxidant systems: role of pituitary and pituitary-dependent axes.

Authors:  A Mancini; R Festa; V Di Donna; E Leone; G P Littarru; A Silvestrini; E Meucci; A Pontecorvi
Journal:  J Endocrinol Invest       Date:  2010-06       Impact factor: 4.256

4.  N-terminal pro-brain natriuretic peptide determination as a possible marker of cardiac dysfunction in patients with adrenal disorders.

Authors:  L Iorio; R Rigolini; E Costa; O Cotta; S Cannavò; B Ambrosi
Journal:  J Endocrinol Invest       Date:  2010 Jul-Aug       Impact factor: 4.256

5.  Echocardiographic alterations in patients with non-functioning adrenal incidentaloma.

Authors:  F Ermetici; C Dall'Asta; A E Malavazos; C Coman; L Morricone; V Montericcio; B Ambrosi
Journal:  J Endocrinol Invest       Date:  2008-06       Impact factor: 4.256

Review 6.  Glucocorticoid-induced hypertension.

Authors:  Julie E Goodwin; David S Geller
Journal:  Pediatr Nephrol       Date:  2011-07-09       Impact factor: 3.714

Review 7.  How mental stress affects endothelial function.

Authors:  Noboru Toda; Megumi Nakanishi-Toda
Journal:  Pflugers Arch       Date:  2011-09-23       Impact factor: 3.657

8.  Blood pressure in pediatric patients with Cushing syndrome.

Authors:  Maya B Lodish; Ninet Sinaii; Nicholas Patronas; Dalia L Batista; Meg Keil; Jonelle Samuel; Jason Moran; Somya Verma; Jadranka Popovic; Constantine A Stratakis
Journal:  J Clin Endocrinol Metab       Date:  2009-03-17       Impact factor: 5.958

9.  Blockade of glucocorticoid receptors with RU486 attenuates cardiac damage and adipose tissue inflammation in a rat model of metabolic syndrome.

Authors:  Yuuri Takeshita; Shogo Watanabe; Takuya Hattori; Kai Nagasawa; Natsumi Matsuura; Keiji Takahashi; Toyoaki Murohara; Kohzo Nagata
Journal:  Hypertens Res       Date:  2015-07-09       Impact factor: 3.872

10.  Chronic blockade of hindbrain glucocorticoid receptors reduces blood pressure responses to novel stress and attenuates adaptation to repeated stress.

Authors:  Andrea G Bechtold; Gina Patel; Guenther Hochhaus; Deborah A Scheuer
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2009-03-11       Impact factor: 3.619

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.